Cargando…

Levosimendan versus dobutamine in septic shock

Detalles Bibliográficos
Autores principales:	Alhashemi, JA, Alotaibi, Q
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084057/ http://dx.doi.org/10.1186/cc7335

Ejemplares similares

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Levosimendan versus dobutamine in Tako-tsubo cardiomyopathy
por: Righetti, FR, et al.
Publicado: (2013)

Effects of simultaneously infused terlipressin and dobutamine in septic shock
por: Morelli, A, et al.
Publicado: (2007)

Combined effects of ivabradine with dobutamine or levosimendan in isolated perfused hearts
por: Konrad, D, et al.
Publicado: (2013)

Evaluation of the cardiac effects of norepinephrine and dobutamine in rats with septic shock
por: Goncalves, Ronald PM, et al.
Publicado: (2013)

Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial
por: Meng, Jian-biao, et al.
Publicado: (2016)

Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
por: Morelli, A, et al.
Publicado: (2009)

Influence of temperature on the cardiac action of dobutamine and levosimendan in isolated perfused hearts
por: Aldenhoff, U, et al.
Publicado: (2013)

Effects of levosimendan on renal function in septic shock: a case–control study
por: Morelli, A, et al.
Publicado: (2009)

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Effects of levosimendan on cellular metabolic alterations in patients with septic shock: a randomised controlled study
por: Meddeb, B, et al.
Publicado: (2015)

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)

Levosimendan in patients with acute cardiogenic shock, not responders to conventional therapy
por: Vetrugno, L, et al.
Publicado: (2007)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

Levosimendan therapy does not improve survival of post-resuscitation cardiogenic shock patients
por: Soos, P, et al.
Publicado: (2009)

The effects of levosimendan and dobutamine in experimental bupivacaine-induced cardiotoxicity
por: Kandemir, Ulku, et al.
Publicado: (2013)

Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
por: Lyhne, Mads D., et al.
Publicado: (2021)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Dopamine versus norepinephrine in septic shock: a meta-analysis
por: Shenoy, S, et al.
Publicado: (2011)

Vasopressin versus norepinephrine for the management of septic shock in cancer patients
por: Zambolim, C, et al.
Publicado: (2014)

Dobutamine protects lymphocytes against staurosporin-induced apoptosis: investigation of the antioxidative action of the dobutamine molecule
por: Van Melkebeek, J, et al.
Publicado: (2008)

Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)

Bioreactance versus PICCOTD/PC in critically ill septic shock patients
por: Monti, G, et al.
Publicado: (2010)

Continuous terlipressin versus vasopressin infusion in septic shock: the TERLIVAP study
por: Morelli, A, et al.
Publicado: (2008)

Prognostic factors of septic shock
por: Quenot, JP, et al.
Publicado: (2012)

Fluid responsiveness in septic shock
por: Righetti, F, et al.
Publicado: (2014)

Homocysteine levels in septic shock
por: Mateu Campos, L, et al.
Publicado: (2015)

Cytokine levels is septic shock
por: Mateu Campos, L, et al.
Publicado: (2015)

Burden of septic shock in the uk
por: Andersson, F, et al.
Publicado: (2015)

Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis
por: Liu, Dong-Hua, et al.
Publicado: (2021)

Sublingual leukocyte activation in patients with severe sepsis or septic shock
por: Fabian-Jessing, BK, et al.
Publicado: (2015)

Effect of transfusion, leukocyte-depleted blood product on onset of new septic shock and mortality in septic shock
por: Hayami, H, et al.
Publicado: (2010)

Nandrolone abuse aggravates septic shock
por: Hsu, YF, et al.
Publicado: (2009)

Lipopolysaccharide adsorber in abdominal septic shock
por: Ala-Kokko, T, et al.
Publicado: (2009)

Early use of immunoglobulin in septic shock
por: Cavazzuti, IC, et al.
Publicado: (2010)

Endotoxin removal by hemoperfusion in septic shock
por: Adamik, B, et al.
Publicado: (2011)

Kinetics of immunoglobulins in septic shock patients
por: Siqueira, C, et al.
Publicado: (2011)

Carbon dioxide output in septic shock
por: Pilas, V, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ng5p9rnctsccr87503t3382jac